H-CYTE Combines Clinical Outcomes and Scientific Development to Launch New Centers for Respiratory Health

Author's Avatar
Sep 08, 2021

Name change reflects investment in, and emphasis on, data-driven, patient-centric care relating to the company’s innovative PRP-PBMC treatment for chronic lung disorders.